/
/
/

Kilitch Drugs (India) Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Sep 2012Jun 2012Sep 2011Jun 2011Jun 2010
₹45 Cr₹90 Cr₹54 Cr₹49 Cr₹43 Cr₹61 Cr₹56 Cr₹47 Cr₹33 Cr₹45 Cr₹32 Cr₹41 Cr₹37 Cr₹45 Cr₹30 Cr₹31 Cr₹33 Cr₹37 Cr₹34 Cr₹24 Cr₹20 Cr₹20 Cr₹20 Cr₹18 Cr₹10 Cr₹12 Cr₹16 Cr₹15 Cr₹10 Cr₹19 Cr₹8 Cr₹27 Cr₹28 Cr₹7 Cr₹15 Cr₹33 Cr₹31 Cr₹32 Cr
₹3 Cr₹49 L₹2 Cr₹7 Cr₹3 Cr₹2 Cr₹2 Cr₹5 Cr₹3 Cr₹47 L₹3 Cr₹49 L₹56 L₹1 Cr₹69 L₹24 L₹97 L₹38 L₹1 Cr₹17 L₹1 Cr₹2 Cr₹37 L₹42 L₹37 L₹1 Cr₹69 L₹59 L₹1 Cr-₹62 L₹33 L₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹23 L₹3 L₹0
₹48 Cr₹90 Cr₹55 Cr₹56 Cr₹46 Cr₹63 Cr₹58 Cr₹53 Cr₹36 Cr₹45 Cr₹35 Cr₹42 Cr₹37 Cr₹46 Cr₹31 Cr₹31 Cr₹34 Cr₹37 Cr₹36 Cr₹24 Cr₹21 Cr₹21 Cr₹21 Cr₹18 Cr₹11 Cr₹13 Cr₹17 Cr₹16 Cr₹12 Cr₹19 Cr₹9 Cr₹29 Cr₹30 Cr₹9 Cr₹19 Cr₹34 Cr₹31 Cr₹32 Cr
₹43 Cr₹68 Cr₹49 Cr₹45 Cr₹41 Cr₹47 Cr₹48 Cr₹42 Cr₹33 Cr₹39 Cr₹30 Cr₹33 Cr₹31 Cr₹40 Cr₹27 Cr₹28 Cr₹31 Cr₹33 Cr₹34 Cr₹21 Cr₹19 Cr₹20 Cr₹18 Cr₹16 Cr₹12 Cr₹14 Cr₹15 Cr₹14 Cr₹12 Cr₹17 Cr₹12 Cr₹23 Cr₹25 Cr₹9 Cr₹16 Cr₹27 Cr₹26 Cr₹27 Cr
₹6 Cr₹23 Cr₹8 Cr₹12 Cr₹6 Cr₹16 Cr₹10 Cr₹11 Cr₹4 Cr₹8 Cr₹5 Cr₹9 Cr₹7 Cr₹7 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr-₹74 L-₹83 L₹2 Cr₹2 Cr₹65 L₹2 Cr-₹3 Cr₹6 Cr₹6 Cr₹17 L₹3 Cr₹8 Cr₹6 Cr₹7 Cr
₹88 L₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹31 L₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹67 L₹71 L₹24 L₹12 L₹13 L₹16 L₹12 L₹18 L₹29 L₹23 L₹17 L₹16 L₹15 L₹38 L₹0₹0₹0₹4 L₹3 L₹18 L₹1 Cr₹77 L
₹4 Cr₹20 Cr₹6 Cr₹9 Cr₹3 Cr₹14 Cr₹8 Cr₹10 Cr₹2 Cr₹5 Cr₹3 Cr₹7 Cr₹4 Cr₹5 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr₹3 Cr₹3 Cr-₹2 Cr-₹2 Cr₹1 Cr₹2 Cr₹6 L₹1 Cr-₹4 Cr₹6 Cr₹5 Cr-₹21 L₹3 Cr₹6 Cr₹4 Cr₹5 Cr
₹2 Cr₹15 Cr₹4 Cr₹8 Cr₹2 Cr₹10 Cr₹6 Cr₹9 Cr₹11 L₹4 Cr₹2 Cr₹5 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹61 L₹3 Cr₹72 L₹71 L₹2 Cr₹2 Cr-₹1 Cr-₹1 Cr₹95 L₹1 Cr-₹19 L₹50 L-₹5 Cr₹4 Cr₹4 Cr-₹23 L₹3 Cr₹5 Cr₹3 Cr₹4 Cr

Share Price Live Stats

Open (₹)172.80
Volume (₹)26,266.00
High (₹)181.14
Upper Circuit181.14
Low (₹)172.80
Lower Circuit163.90
Prev Close172.52
52W High (₹)219.50
Price181.14
52W Low (₹)117.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)599.77 Cr
Div. Yield (%)0.00
PE Ratio19.96
Debt to Equity0.32
Price to Book1.60
Book Value79.89
EPS (TTM)8.60
Face Value10.00
ROE (%)12.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
KILITCH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1900.8-19.2 (-1.00%)
1896.80
1984.80
4,56,833Cr
9146-93 (-1.01%)
9087
9467
2,45,426Cr
4829-221 (-4.38%)
4823
5066
1,87,320Cr
1128.8-62.2 (-5.22%)
1125.10
1187
1,13,217Cr
1381-42.5 (-2.99%)
1376
1426.10
1,12,212Cr
1846.2-92.3 (-4.76%)
1811.70
1949
1,01,155Cr
2109.8-61.7 (-2.84%)
2107.20
2192
97,626Cr
2330.3-52.6 (-2.21%)
2327.30
2419.20
96,859Cr
1157.4-20.6 (-1.75%)
1154.40
1179.90
96,406Cr
1653.2+7.9 (0.48%)
1622.60
1717
93,614Cr
181.14+9.37 (5.45%)
166.15
181.14
600Cr

Key Highlights of Kilitch Drugs (India) Ltd’s P&L

In 2026-03-31, Kilitch Drugs (India) Ltd reported total revenue of ₹246.72Cr, compared with ₹209.48Cr in 2025-03-31, reflecting Kilitch Drugs (India) Ltd turnover.

Depreciation was ₹3.62Cr and finance costs were ₹6.29Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹38.65Cr in 2026-03-31 as compared to ₹34.47Cr in 2025-03-31.

Net Profit (PAT) was ₹30.17Cr in 2026-03-31 compared with ₹26.7Cr in 2025-03-31.

Earnings per share (EPS) were ₹8.63 in 2026-03-31, compared with ₹16.60 in 2025-03-31.